BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:44 PM
Aug 31, 2012
 |  BC Extra  |  Company News

J&J unit seeks EU approval of TB therapy

Janssen-Cilag International N.V. submitted an MAA to EMA for bedaquiline ( TMC207) to treat multi-drug resistant...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >